A detailed history of Capstone Wealth Management Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capstone Wealth Management Group, LLC holds 456 shares of LLY stock, worth $403,988. This represents 0.27% of its overall portfolio holdings.

Number of Shares
456
Previous 454 0.44%
Holding current value
$403,988
Previous $353,000 16.71%
% of portfolio
0.27%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $1,449 - $1,818
2 Added 0.44%
456 $412,000
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 1.11%
454 $353,000
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $36,763 - $43,339
70 Added 18.47%
449 $261,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $164,751 - $227,134
379 New
379 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capstone Wealth Management Group, LLC Portfolio

Follow Capstone Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Wealth Management Group, LLC with notifications on news.